<?xml version="1.0" encoding="UTF-8"?>
<results title="disease">
 <result pre="the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). Abstract This" exact="short" post="review is focused on enzymatic properties of human ATP-dependent"/>
 <result pre="processes, such as cell cycle progression, apoptosis, innate immune response," exact="viral" post="replication, and tumorigenesis. DDX3 has a variety of functions"/>
 <result pre="to facilitate both the Rev-mediated export of unspliced/partially spliced human" exact="immunodeficiency" post="virus (HIV) RNA from nucleus and Tat-dependent translation of"/>
 <result pre="immunodeficiency virus (HIV) RNA from nucleus and Tat-dependent translation of" exact="viral" post="genes. DDX3 silencing blocks the replication of HIV, HCV,"/>
 <result pre="viruses. On the other hand, DDX displays antiviral effect against" exact="Dengue" post="virus and hepatitis B virus through the stimulation of"/>
 <result pre="other hand, DDX displays antiviral effect against Dengue virus and" exact="hepatitis" post="B virus through the stimulation of interferon beta production."/>
 <result pre="beta production. The role of DDX3 in different types of" exact="cancer" post="is rather controversial. DDX3 acts as an oncogene in"/>
 <result pre="as an oncogene in one type of cancer, but demonstrates" exact="tumor" post="suppressor properties in other types. The human DDX3 helicase"/>
 <result pre="actions as antiviral or anticancer drugs are discussed in this" exact="short" post="review. DEAD-box family RNA helicases physico-chemical properties antiviral drug"/>
 <result pre="use host metabolic machinery for their replication and emission of" exact="infection" post="[1]. More than 300 cellular proteins and co-factors participate"/>
 <result pre="by the Food and Drug Administration for the treatment of" exact="viral" post="infections include drugs targeting viral enzymes. In the case"/>
 <result pre="the Food and Drug Administration for the treatment of viral" exact="infections" post="include drugs targeting viral enzymes. In the case of"/>
 <result pre="Administration for the treatment of viral infections include drugs targeting" exact="viral" post="enzymes. In the case of human immunodeficiency virus (HIV),"/>
 <result pre="include drugs targeting viral enzymes. In the case of human" exact="immunodeficiency" post="virus (HIV), the main targets are the reverse transcriptase,"/>
 <result pre="for the treatment of HIV-infected people. For the treatment of" exact="hepatitis" post="C virus (HCV)-infected patients, inhibitors of HCV NS3/4A protease,"/>
 <result pre="problem with such an approach is the rapid development of" exact="viral" post="resistance and escape of some genotypes/isolates from the action"/>
 <result pre="for drug development can help to overcome the problem of" exact="viral" post="resistance, since cellular proteins are much more conserved, and"/>
 <result pre="in all aspects of RNA metabolism, cell cycle regulation, and" exact="viral infection." post="The DDX3 helicase is involved in the replication of"/>
 <result pre="the replication of viruses belonging to different families: HCV [12]," exact="Dengue" post="virus [13,14], Japanese encephalitis virus [15], and West Nile"/>
 <result pre="viruses belonging to different families: HCV [12], Dengue virus [13,14]," exact="Japanese encephalitis" post="virus [15], and West Nile virus of the Flaviviridae"/>
 <result pre="belonging to different families: HCV [12], Dengue virus [13,14], Japanese" exact="encephalitis" post="virus [15], and West Nile virus of the Flaviviridae"/>
 <result pre="of the Flaviviridae family [16], HIV [17,18] of the Retroviridae," exact="hepatitis" post="B virus (HBV) [19] of Hepadnaviridae, Vaccinia virus of"/>
 <result pre="of the Retroviridae, hepatitis B virus (HBV) [19] of Hepadnaviridae," exact="Vaccinia" post="virus of Poxviridae [20], Norovirus of Caliciviridae [21], influenza"/>
 <result pre="helicases are composed of two RecA-like domains connected via a" exact="short" post="flexible linker that allows changing their orientation to each"/>
 <result pre="members of the DEAD-box family, whereas the differences are mainly" exact="localized" post="in the tail fragments [34]. It should be noted"/>
 <result pre="to three DDX3 molecules without translocation, and can completely separate" exact="short" post="RNA-RNA or RNA-DNA duplexes using a single ATP molecule"/>
 <result pre="non-hydrolyzable ATP analog ADP-beryllium fluoride (ADP-BeF) can promote unwinding the" exact="short" post="oligonucleotide duplex, although other non-hydrolyzable ATP analogs, ADP-aluminum fluoride"/>
 <result pre="do not provide RNA-RNA complex separation [46] but can form" exact="stable" post="complexes with RNA [33,47]. Probably, minor differences in the"/>
 <result pre="Moreover, ATPase activity is stimulated by DNA to a markedly" exact="lower" post="level than that by RNA, and no significant ATPase"/>
 <result pre="that by RNA, and no significant ATPase activity in the" exact="absence of" post="nucleic acid [45]. A virtual analysis of the interaction"/>
 <result pre="those with 5’-unpaired regions and the inability to separate DNA-DNA" exact="complete" post="duplexes. Fully double-stranded complexes DNA-RNA but not DNA-DNA can"/>
 <result pre="slower. 3. Hypothetical Mechanisms of the DDX3 Helicase Role in" exact="Viral" post="Replication DDX3 helicase is a multifunctional protein interacting with"/>
 <result pre="helicase is a multifunctional protein interacting with many human and" exact="viral" post="proteins and their complexes with RNA [17,48], but its"/>
 <result pre="their complexes with RNA [17,48], but its role in the" exact="viral" post="replication of different viruses has not been studied precisely."/>
 <result pre="It was shown that DDX3 plays a dual function in" exact="viral" post="replication: first, as a cofactor of viral replication, and"/>
 <result pre="dual function in viral replication: first, as a cofactor of" exact="viral" post="replication, and second, as a mediator of the innate"/>
 <result pre="of the innate immunity system. The role of helicases in" exact="viral infection" post="was discussed in several reviews [9,50,51]. Viruses recruit cellular"/>
 <result pre="the innate immunity system. The role of helicases in viral" exact="infection" post="was discussed in several reviews [9,50,51]. Viruses recruit cellular"/>
 <result pre="can be partly explained by unfolding of the HIV RNA" exact="secondary" post="structure by the DDX3 helicase or shaking off associated"/>
 <result pre="with HIV translation factor Tat, which facilitates Tat-dependent translation of" exact="viral" post="genes [55,59]. In contrast to DDX3 functions facilitating viral"/>
 <result pre="of viral genes [55,59]. In contrast to DDX3 functions facilitating" exact="viral" post="mRNA transport and translation, DDX3 participates in the anti-viral"/>
 <result pre="participates in the anti-viral innate immune signaling pathway, leading to" exact="type I" post="IFN induction after phosphorylation by TBK1/IKKε and translocation into"/>
 <result pre="the input of interferon signaling in the control of HCV" exact="infection" post="and the precise role of DDX3 in its modulation"/>
 <result pre="[67,74]. Lipid droplets are the ER-derived organelles on which several" exact="viral" post="proteins, including HCV core, are localized. Moreover, the initial"/>
 <result pre="formation via affecting NS5A, whose phosphorylation affects the interaction of" exact="viral" post="RNA with RNA-dependent RNA polymerase [77] or HCV core"/>
 <result pre="with lipid droplets [87]. Noteworthy, SG assembly is inhibited in" exact="tumor" post="cells harboring DDX3 with tumor-associated mutations [88], i.e., the"/>
 <result pre="family and for Picornaviruses. DDX3 interacts with UTRs of the" exact="Japanese Encephalitis" post="virus and with its NS3 and NS5A proteins also"/>
 <result pre="and for Picornaviruses. DDX3 interacts with UTRs of the Japanese" exact="Encephalitis" post="virus and with its NS3 and NS5A proteins also"/>
 <result pre="and NS5A proteins also to promote late stages of the" exact="viral" post="life cycle [15]. The West Nile virus sequesters DDX3"/>
 <result pre="West Nile virus sequesters DDX3 from P-bodies to sites of" exact="viral" post="replication, thus affecting the functioning of these organelles but"/>
 <result pre="the only virus whose virions contain DDX3. Another example is" exact="herpes" post="simplex virus type 1 (HSV-1) [100]. However, in this"/>
 <result pre="whose virions contain DDX3. Another example is herpes simplex virus" exact="type 1" post="(HSV-1) [100]. However, in this case, DDX3 acts not"/>
 <result pre="a proviral factor [101], presumably by affecting the expression of" exact="viral" post="genes and regulating virion assembly [102]. This could be"/>
 <result pre="virion assembly [102]. This could be a feature of various" exact="herpes" post="viruses, as similar data point to DDX3 as a"/>
 <result pre="NS1 and NP proteins [22]. DDX3 is also recruited to" exact="viral" post="replicase [105], presumably by interaction with PB1-F2 (a subunit"/>
 <result pre="replicase [105], presumably by interaction with PB1-F2 (a subunit of" exact="viral" post="replicase) [106]. In the case of the latter, such"/>
 <result pre="strain, and results in a co-degradation of both DDX3 and" exact="viral" post="protein [106]. So, it could be one of the"/>
 <result pre="of the factors of an extremely high pathogenicity of this" exact="viral" post="strain. Another factor is an NS1- and NP-induced DDX3-mediated"/>
 <result pre="through stimulator of interferon genes (STING) [107]—another cytoplasmic sensor of" exact="viral" post="nucleic acids. However, contrary data also exist. Diot et"/>
 <result pre="proteins, with DDX19 helicase being the most effective in reducing" exact="infectious" post="IAV [108]. Finally, DDX3 may be a cellular factor"/>
 <result pre="formation of lipid droplets [74], thus contributing to the development" exact="of liver" post="steatosis, one of the common liver diseases in chronic"/>
 <result pre="of lipid droplets [74], thus contributing to the development of" exact="liver steatosis," post="one of the common liver diseases in chronic hepatitis"/>
 <result pre="of liver steatosis, one of the common liver diseases in" exact="chronic hepatitis" post="C patients. An additional link between HCV-induced changes in"/>
 <result pre="liver steatosis, one of the common liver diseases in chronic" exact="hepatitis" post="C patients. An additional link between HCV-induced changes in"/>
 <result pre="development of inflammation during various infections, including HCV, HIV, and" exact="respiratory" post="viruses [112,113,114]. Indeed, in the case of HIV, DDX3"/>
 <result pre="DDX3 helicase as well as blocking virus replication or suppressing" exact="tumor" post="progression. The first potential DDX3 inhibitors were synthesized after"/>
 <result pre="them as suppressors of virus replication in cell cultures and" exact="tumor" post="aggression. Among the active compounds were derivatives of rhodanine,"/>
 <result pre="IC50 0.3 μM and displayed inhibiting potential against HIV, HCV," exact="Dengue" post="virus, and West Nile virus replication in cell cultures,"/>
 <result pre="μM for HIV, 0.97 μM for HCV, 2.55 μM for" exact="Dengue" post="virus, and suppressed West Nile virus replication by 98%"/>
 <result pre="systems (RENs). The compounds strongly inhibit human DDX3 helicase, HCV" exact="viral" post="helicases (NS3 helicase), helicases of West Nile virus, and"/>
 <result pre="viral helicases (NS3 helicase), helicases of West Nile virus, and" exact="Japanese encephalitis" post="virus in a cell-free system, and, as a result,"/>
 <result pre="helicases (NS3 helicase), helicases of West Nile virus, and Japanese" exact="encephalitis" post="virus in a cell-free system, and, as a result,"/>
 <result pre="HCV is a frequent co-infection in AIDS patients, leading to" exact="liver cirrhosis" post="and death. As supposed, the compounds mimic nucleoside, occupy"/>
 <result pre="is a frequent co-infection in AIDS patients, leading to liver" exact="cirrhosis" post="and death. As supposed, the compounds mimic nucleoside, occupy"/>
 <result pre="mimic nucleoside, occupy the ATP binding site of human or" exact="viral" post="helicases and delay or interrupt virus replication. The toxicity"/>
 <result pre="antiviral but also anticancer activities. The role of DDX3 in" exact="cancer" post="development is rather controversial. DDX3 helicase can act as"/>
 <result pre="rather controversial. DDX3 helicase can act as an oncogene or" exact="tumor" post="suppressor in different cancer types [26,27,116,121,122,123,124,125]. Moreover, DDX3 may"/>
 <result pre="can act as an oncogene or tumor suppressor in different" exact="cancer" post="types [26,27,116,121,122,123,124,125]. Moreover, DDX3 may play different roles in"/>
 <result pre="For example, a decreased level of DDX3 was found in" exact="hepatocellular carcinoma" post="(HCC) caused by HBV, although not by HCV [126]."/>
 <result pre="example, a decreased level of DDX3 was found in hepatocellular" exact="carcinoma" post="(HCC) caused by HBV, although not by HCV [126]."/>
 <result pre="not by HCV [126]. DDX3 also plays dual roles in" exact="breast cancer" post="[127] and colorectal cancer patients [128,129]. Up to now,"/>
 <result pre="by HCV [126]. DDX3 also plays dual roles in breast" exact="cancer" post="[127] and colorectal cancer patients [128,129]. Up to now,"/>
 <result pre="DDX3 also plays dual roles in breast cancer [127] and" exact="colorectal cancer" post="patients [128,129]. Up to now, there is no exact"/>
 <result pre="also plays dual roles in breast cancer [127] and colorectal" exact="cancer" post="patients [128,129]. Up to now, there is no exact"/>
 <result pre="Wnt regulation cascade, which is crucial to DDX3 functions in" exact="cancer" post="development [130]. DDX3 also modulates cell adhesion, represses the"/>
 <result pre="expression, which results in increased cell migration, and thus promotes" exact="tumor" post="progression [131]. As supposed, different roles of DDX helicases"/>
 <result pre="or virus infections, particularly HCV or HBV. DDX3 knockdown with" exact="short" post="interfering RNA (shRNA) or small molecules suppressed cell motility"/>
 <result pre="RNA (shRNA) or small molecules suppressed cell motility and reduced" exact="metastatic" post="potential in cancer cells and a mouse model [43,131]."/>
 <result pre="small molecules suppressed cell motility and reduced metastatic potential in" exact="cancer" post="cells and a mouse model [43,131]. The localization of"/>
 <result pre="also reports of DDX3 export from nucleus to cytoplasm during" exact="tumor" post="progression. DDX3 helicase is a nucleo-cytoplasmic shuttling protein predominantly"/>
 <result pre="tumor progression. DDX3 helicase is a nucleo-cytoplasmic shuttling protein predominantly" exact="localized" post="in the cytoplasm of non-malignant cells. It has been"/>
 <result pre="activity, blocking cell replication at the G1 phase of aggressive" exact="breast cancer" post="in different cell cultures [43], causing a global delay"/>
 <result pre="blocking cell replication at the G1 phase of aggressive breast" exact="cancer" post="in different cell cultures [43], causing a global delay"/>
 <result pre="the DDX3 gene. Unfortunately, NZ51 treatment had no effect on" exact="primary" post="tumor growth rates in a mouse model system, although"/>
 <result pre="DDX3 gene. Unfortunately, NZ51 treatment had no effect on primary" exact="tumor" post="growth rates in a mouse model system, although DDX3"/>
 <result pre="model system, although DDX3 knockdown by shRNA resulted in reduced" exact="tumor" post="volume and metastasis progression [43]. Among ring-expanded derivatives, the"/>
 <result pre="DDX3 knockdown by shRNA resulted in reduced tumor volume and" exact="metastasis" post="progression [43]. Among ring-expanded derivatives, the compound RK33 proved"/>
 <result pre="(Figure 4). RK-33 was found to display antiproliferative activity against" exact="Ewing sarcoma" post="[136], breast cancer [137], medulloblastoma [25], colorectal [129], prostate"/>
 <result pre="4). RK-33 was found to display antiproliferative activity against Ewing" exact="sarcoma" post="[136], breast cancer [137], medulloblastoma [25], colorectal [129], prostate"/>
 <result pre="was found to display antiproliferative activity against Ewing sarcoma [136]," exact="breast cancer" post="[137], medulloblastoma [25], colorectal [129], prostate [138], and lung"/>
 <result pre="found to display antiproliferative activity against Ewing sarcoma [136], breast" exact="cancer" post="[137], medulloblastoma [25], colorectal [129], prostate [138], and lung"/>
 <result pre="display antiproliferative activity against Ewing sarcoma [136], breast cancer [137]," exact="medulloblastoma" post="[25], colorectal [129], prostate [138], and lung [116] cancer,"/>
 <result pre="that allows a reduction in the dose of radiation for" exact="cancer" post="treatment [45]. The precise mechanism of RK-33 action in"/>
 <result pre="The precise mechanism of RK-33 action in different types of" exact="cancer" post="remains to be elucidated. There is evidence that the"/>
 <result pre="the Wnt signaling pathway involved in cell differentiation, cell proliferation," exact="malignant" post="tumors, and transition of the G1/S cell cycle [131]."/>
 <result pre="considered a potential new chemotherapeutic target for the treatment of" exact="viral" post="infections and different types of cancer. There are about"/>
 <result pre="a potential new chemotherapeutic target for the treatment of viral" exact="infections" post="and different types of cancer. There are about 50"/>
 <result pre="human DEAD-box helicases involved in a variety of cellular and" exact="viral" post="metabolic processes. In spite of the fact that interfering"/>
 <result pre="inhibitors of DDX3 enzymatic activity have been developed, which suppress" exact="viral" post="replication in cell cultures and display anticancer activity against"/>
 <result pre="cell cultures and display anticancer activity against a number of" exact="cancer" post="types without significant toxicity. One of the inhibitors of"/>
 <result pre="DDX3, ATPase RK-33, was recommended for the preclinical stage against" exact="lung cancer." post="Moreover, RK33 increases radiosensitivity, which allows a reduction in"/>
 <result pre="which allows a reduction in the dose of radiation for" exact="cancer" post="treatment. Little is currently known about the mechanisms for"/>
 <result pre="treatment. Little is currently known about the mechanisms for suppressing" exact="viral" post="infections and regression of tumors with DDX helicase inhibitors."/>
 <result pre="Little is currently known about the mechanisms for suppressing viral" exact="infections" post="and regression of tumors with DDX helicase inhibitors. Sometimes"/>
 <result pre="to unveil the mechanism of suppression of virus replication and" exact="tumor" post="repression. However, the results obtained allow us to hope"/>
 <result pre="version of the manuscript. Funding This research was funded by" exact="Russian" post="Foundation for Basic Research (grant 18-04-000735) and by the"/>
 <result pre="by the Ministry of Science and Higher Education of the" exact="Russian" post="Federation (Agreement No. 075-15-2019-1660). Conflicts of Interest The authors"/>
 <result pre="functions of DDX3 RNA helicase in gene regulation, tumorigenesis, and" exact="viral" post="infectionFront Genet.2014542310.3389/fgene.2014.0042325538732 10.BolG.M.XieM.RamanV.DDX3, a potential target for cancer treatmentMol."/>
 <result pre="tumorigenesis, and viral infectionFront Genet.2014542310.3389/fgene.2014.0042325538732 10.BolG.M.XieM.RamanV.DDX3, a potential target for" exact="cancer" post="treatmentMol. Cancer20151418810.1186/s12943-015-0461-726541825 11.SchroderM.Viruses and the human DEAD-box helicase DDX3:"/>
 <result pre="DDX3: Inhibition or exploitation?Biochem. Soc. Trans.20113967968310.1042/BST039067921428961 12.UpadyaM.H.AweyaJ.J.TanY.J.Understanding the interaction of" exact="hepatitis" post="C virus with host DEAD-box RNA helicasesWorld J. Gastroenterol.2014202913292610.3748/wjg.v20.i11.291324659882"/>
 <result pre="with DDX3X-A Potential Mechanism for Suppression of Antiviral Functions in" exact="Dengue" post="InfectionFront Cell Infect. Microbiol.2017754210.3389/fcimb.2017.0054229387631 14.LiG.FengT.PanW.ShiX.DaiJ.DEAD-box RNA helicase DDX3X inhibits"/>
 <result pre="one interferon pathwayBiochem. Biophys. Res. Commun.201545632733210.1016/j.bbrc.2014.11.08025437271 15.LiC.GeL.L.LiP.P.WangY.DaiJ.J.SunM.X.HuangL.ShenZ.Q.HuX.C.IshagH.et al.Cellular DDX3 regulates" exact="Japanese encephalitis" post="virus replication by interacting with viral un-translated regionsVirology2014449708110.1016/j.virol.2013.11.00824418539 16.BraiA.MartelliF.RivaV.GarbelliA.FaziR.ZamperiniC.PollutriA.FalsittaL.RonziniS.MaccariL.et"/>
 <result pre="interferon pathwayBiochem. Biophys. Res. Commun.201545632733210.1016/j.bbrc.2014.11.08025437271 15.LiC.GeL.L.LiP.P.WangY.DaiJ.J.SunM.X.HuangL.ShenZ.Q.HuX.C.IshagH.et al.Cellular DDX3 regulates Japanese" exact="encephalitis" post="virus replication by interacting with viral un-translated regionsVirology2014449708110.1016/j.virol.2013.11.00824418539 16.BraiA.MartelliF.RivaV.GarbelliA.FaziR.ZamperiniC.PollutriA.FalsittaL.RonziniS.MaccariL.et"/>
 <result pre="al.Cellular DDX3 regulates Japanese encephalitis virus replication by interacting with" exact="viral" post="un-translated regionsVirology2014449708110.1016/j.virol.2013.11.00824418539 16.BraiA.MartelliF.RivaV.GarbelliA.FaziR.ZamperiniC.PollutriA.FalsittaL.RonziniS.MaccariL.et al.DDX3X Helicase Inhibitors as a New"/>
 <result pre="of helicases in HIV-1 ReplicationRetrovirology201297910.1186/1742-4690-9-7923020886 19.WangH.KimS.RyuW.S.DDX3 DEAD-Box RNA helicase inhibits" exact="hepatitis" post="B virus reverse transcription by incorporation into nucleocapsidsJ. Virol.2009835815582410.1128/JVI.00011-0919297497"/>
 <result pre="Granule FormationJ. Virol.2016903661367510.1128/JVI.03010-1526792746 23.IshaqM.HuJ.WuX.FuQ.YangY.LiuQ.GuoD.Knockdown of cellular RNA helicase DDX3 by" exact="short" post="hairpin RNAs suppresses HIV-1 viral replication without inducing apoptosisMol."/>
 <result pre="cellular RNA helicase DDX3 by short hairpin RNAs suppresses HIV-1" exact="viral" post="replication without inducing apoptosisMol. Biotechnol.20083923123810.1007/s12033-008-9040-018259889 24.LaiM.C.LeeY.H.TarnW.Y.The DEAD-box RNA helicase"/>
 <result pre="participates in translational controlMol. Biol. Cell2008193847385810.1091/mbc.e07-12-126418596238 25.TantravediS.VesunaF.WinnardP.T.Jr.MartinA.LimM.EberhartC.G.BerlinickeC.RaabeE.van DiestP.J.RamanV.Targeting DDX3 in" exact="Medulloblastoma" post="Using the Small Molecule Inhibitor RK-33Transl. Oncol.2019129610510.1016/j.tranon.2018.09.00230292066 26.ZhaoL.MaoY.ZhouJ.ZhaoY.CaoY.ChenX.Multifunctional DDX3:"/>
 <result pre="Molecule Inhibitor RK-33Transl. Oncol.2019129610510.1016/j.tranon.2018.09.00230292066 26.ZhaoL.MaoY.ZhouJ.ZhaoY.CaoY.ChenX.Multifunctional DDX3: Dual roles in various" exact="cancer" post="development and its related signaling pathwaysAm. J. Cancer Res.2016638740227186411"/>
 <result pre="in various cancer development and its related signaling pathwaysAm. J." exact="Cancer" post="Res.2016638740227186411 27.BotlaguntaM.VesunaF.MironchikY.RamanA.LisokA.WinnardP.Jr.MukadamS.Van DiestP.ChenJ.H.FarabaughP.et al.Oncogenic role of DDX3 in breast"/>
 <result pre="J. Cancer Res.2016638740227186411 27.BotlaguntaM.VesunaF.MironchikY.RamanA.LisokA.WinnardP.Jr.MukadamS.Van DiestP.ChenJ.H.FarabaughP.et al.Oncogenic role of DDX3 in" exact="breast cancer" post="biogenesisOncogene2008273912392210.1038/onc.2008.3318264132 28.AndreouA.Z.KlostermeierD.Conformational changes of DEAD-box helicases monitored by single"/>
 <result pre="Cancer Res.2016638740227186411 27.BotlaguntaM.VesunaF.MironchikY.RamanA.LisokA.WinnardP.Jr.MukadamS.Van DiestP.ChenJ.H.FarabaughP.et al.Oncogenic role of DDX3 in breast" exact="cancer" post="biogenesisOncogene2008273912392210.1038/onc.2008.3318264132 28.AndreouA.Z.KlostermeierD.Conformational changes of DEAD-box helicases monitored by single"/>
 <result pre="43.XieM.VesunaF.BotlaguntaM.BolG.M.IrvingA.BergmanY.HosmaneR.S.KatoY.WinnardP.T.Jr.RamanV.NZ51, a ring-expanded nucleoside analog, inhibits motility and viability of" exact="breast cancer" post="cells by targeting the RNA helicase DDX3Oncotarget20156299012991310.18632/oncotarget.489826337079 44.ZhangN.ZhangP.BaierA.CovaL.HosmaneR.S.Dual inhibition"/>
 <result pre="a ring-expanded nucleoside analog, inhibits motility and viability of breast" exact="cancer" post="cells by targeting the RNA helicase DDX3Oncotarget20156299012991310.18632/oncotarget.489826337079 44.ZhangN.ZhangP.BaierA.CovaL.HosmaneR.S.Dual inhibition"/>
 <result pre="mediators of anti-viral innate immunity and essential host factors for" exact="viral" post="replicationBiochim. Biophys. Acta2013182985486510.1016/j.bbagrm.2013.03.01223567047 51.RanjiA.Boris-LawrieK.RNA helicases: Emerging roles in viral"/>
 <result pre="for viral replicationBiochim. Biophys. Acta2013182985486510.1016/j.bbagrm.2013.03.01223567047 51.RanjiA.Boris-LawrieK.RNA helicases: Emerging roles in" exact="viral" post="replication and the host innate responseRNA Biol.2010777578710.4161/rna.7.6.1424921173576 52.FangJ.KubotaS.YangB.ZhouN.ZhangH.GodboutR.PomerantzR.J.A DEAD"/>
 <result pre="55.LaiM.C.WangS.W.ChengL.TarnW.Y.TsaiS.J.SunH.S.Human DDX3 interacts with the HIV-1 Tat protein to facilitate" exact="viral" post="mRNA translationPLoS ONE20138e6866510.1371/journal.pone.006866523840900 56.NajiS.AmbrusG.CimermancicP.ReyesJ.R.JohnsonJ.R.FilbrandtR.HuberM.D.VeselyP.KroganN.J.YatesJ.R.et al.Host cell interactome of HIV-1"/>
 <result pre="activationMol. Cell Biol.2013332004201510.1128/MCB.01603-1223478265 63.AriumiY.KurokiM.AbeK.DansakoH.IkedaM.WakitaT.KatoN.DDX3 DEAD-box RNA helicase is required for" exact="hepatitis" post="C virus RNA replicationJ. Virol.200781139221392610.1128/JVI.01517-0717855521 64.OwsiankaA.M.PatelA.H.Hepatitis C virus core"/>
 <result pre="putative RNA helicaseJ. Virol.1999732841285310.1128/JVI.73.4.2841-2853.199910074132 67.AngusA.G.DalrympleD.BoulantS.McGivernD.R.ClaytonR.F.ScottM.J.AdairR.GrahamS.OwsiankaA.M.Targett-AdamsP.et al.Requirement of cellular DDX3 for" exact="hepatitis" post="C virus replication is unrelated to its interaction with"/>
 <result pre="C virus replication is unrelated to its interaction with the" exact="viral" post="core proteinJ. Gen. Virol.20109112213210.1099/vir.0.015909-019793905 68.SunC.PagerC.T.LuoG.SarnowP.CateJ.H.Hepatitis C virus core-derived peptides"/>
 <result pre="Gen. Virol.20109112213210.1099/vir.0.015909-019793905 68.SunC.PagerC.T.LuoG.SarnowP.CateJ.H.Hepatitis C virus core-derived peptides inhibit genotype 1b" exact="viral" post="genome replication via interaction with DDX3XPLoS ONE2010510.1371/journal.pone.0012826 69.OshiumiH.IkedaM.MatsumotoM.WatanabeA.TakeuchiO.AkiraS.KatoN.ShimotohnoK.SeyaT.Hepatitis C"/>
 <result pre="function that enhances IPS-1-mediated IFN-beta inductionPLoS ONE20105e1425810.1371/journal.pone.001425821170385 70.KangJ.I.KwonY.C.AhnB.Y.Modulation of the" exact="type I" post="interferon pathways by culture-adaptive hepatitis C virus core mutantsFEBS"/>
 <result pre="ONE20105e1425810.1371/journal.pone.001425821170385 70.KangJ.I.KwonY.C.AhnB.Y.Modulation of the type I interferon pathways by culture-adaptive" exact="hepatitis" post="C virus core mutantsFEBS Lett.20125861272127810.1016/j.febslet.2012.03.06222616990 71.SumpterR.Jr.LooY.M.FoyE.LiK.YoneyamaM.FujitaT.LemonS.M.GaleM.Jr.Regulating intracellular antiviral defense"/>
 <result pre="core mutantsFEBS Lett.20125861272127810.1016/j.febslet.2012.03.06222616990 71.SumpterR.Jr.LooY.M.FoyE.LiK.YoneyamaM.FujitaT.LemonS.M.GaleM.Jr.Regulating intracellular antiviral defense and permissiveness to" exact="hepatitis" post="C virus RNA replication through a cellular RNA helicase,"/>
 <result pre="through a cellular RNA helicase, RIG-IJ. Virol.2005792689269910.1128/JVI.79.5.2689-2699.200515708988 72.AnggakusumaFrentzenA.GurlevikE.YuanQ.SteinmannE.OttM.StaeheliP.Schmid-BurgkJ.SchmidtT.HornungV.et al.Control of" exact="hepatitis" post="C virus replication in mouse liver-derived cells by MAVS-dependent"/>
 <result pre="virus replication in mouse liver-derived cells by MAVS-dependent production of" exact="type I" post="and type III interferonsJ. Virol.2015893833384510.1128/JVI.03129-1425609814 73.VazquezC.TanC.Y.HornerS.M.Hepatitis C Virus Infection"/>
 <result pre="mouse liver-derived cells by MAVS-dependent production of type I and" exact="type III" post="interferonsJ. Virol.2015893833384510.1128/JVI.03129-1425609814 73.VazquezC.TanC.Y.HornerS.M.Hepatitis C Virus Infection Is Inhibited by"/>
 <result pre="type I and type III interferonsJ. Virol.2015893833384510.1128/JVI.03129-1425609814 73.VazquezC.TanC.Y.HornerS.M.Hepatitis C Virus" exact="Infection" post="Is Inhibited by a Noncanonical Antiviral Signaling Pathway Targeted"/>
 <result pre="Noncanonical Antiviral Signaling Pathway Targeted by NS3-NS4AJ. Virol.20199310.1128/JVI.00725-1931534039 74.LiQ.PeneV.KrishnamurthyS.ChaH.LiangT.J.Hepatitis C" exact="virus infection" post="activates an innate pathway involving IKK-alpha in lipogenesis and"/>
 <result pre="Antiviral Signaling Pathway Targeted by NS3-NS4AJ. Virol.20199310.1128/JVI.00725-1931534039 74.LiQ.PeneV.KrishnamurthyS.ChaH.LiangT.J.Hepatitis C virus" exact="infection" post="activates an innate pathway involving IKK-alpha in lipogenesis and"/>
 <result pre="infection activates an innate pathway involving IKK-alpha in lipogenesis and" exact="viral" post="assemblyNat. Med.20131972272910.1038/nm.319023708292 75.VieyresG.PietschmannT.HCV Pit Stop at the Lipid Droplet:"/>
 <result pre="a Lipoprotein Coat before ExitCells2019823310.3390/cells8030233 76.LeeJ.Y.CorteseM.HaselmannU.TabataK.Romero-BreyI.FunayaC.SchieberN.L.QiangY.BartenschlagerM.KallisS.et al.Spatiotemporal Coupling of the" exact="Hepatitis" post="C Virus Replication Cycle by Creating a Lipid Droplet-"/>
 <result pre="Hepatitis C Virus Replication Cycle by Creating a Lipid Droplet-" exact="Proximal" post="Membranous Replication CompartmentCell Rep.20192736023617.e360510.1016/j.celrep.2019.05.06331216478 77.IvanovA.V.TunitskayaV.L.IvanovaO.N.MitkevichV.A.PrassolovV.S.MakarovA.A.KukhanovaM.K.KochetkovS.N.Hepatitis C virus NS5A protein"/>
 <result pre="RNA polymerase in in vitro systemFEBS Lett.200958327728010.1016/j.febslet.2008.12.01619073181 78.MasakiT.SuzukiR.MurakamiK.AizakiH.IshiiK.MurayamaA.DateT.MatsuuraY.MiyamuraT.WakitaT.et al.Interaction of" exact="hepatitis" post="C virus nonstructural protein 5A with core protein is"/>
 <result pre="5A with core protein is critical for the production of" exact="infectious" post="virus particlesJ. Virol.2008827964797610.1128/JVI.00826-0818524832 79.DoldeC.BischofJ.GruterS.MontadaA.HalekotteJ.PeiferC.KalbacherH.BaumannU.KnippschildU.SuterB.A CK1 FRET biosensor reveals that"/>
 <result pre="FrancescoR.NeddermannP.The alpha isoform of protein kinase CKI is responsible for" exact="hepatitis" post="C virus NS5A hyperphosphorylationJ. Virol.200680113051131210.1128/JVI.01465-0616943283 81.MasakiT.MatsunagaS.TakahashiH.NakashimaK.KimuraY.ItoM.MatsudaM.MurayamaA.KatoT.HiranoH.et al.Involvement of hepatitis"/>
 <result pre="for hepatitis C virus NS5A hyperphosphorylationJ. Virol.200680113051131210.1128/JVI.01465-0616943283 81.MasakiT.MatsunagaS.TakahashiH.NakashimaK.KimuraY.ItoM.MatsudaM.MurayamaA.KatoT.HiranoH.et al.Involvement of" exact="hepatitis" post="C virus NS5A hyperphosphorylation mediated by casein kinase I-alpha"/>
 <result pre="C virus NS5A hyperphosphorylation mediated by casein kinase I-alpha in" exact="infectious" post="virus productionJ. Virol.2014887541755510.1128/JVI.03170-1324760886 82.WangW.T.TsaiT.Y.ChaoC.H.LaiB.Y.Wu LeeY.H.Y-Box Binding Protein 1 Stabilizes"/>
 <result pre="kinase I-alpha in infectious virus productionJ. Virol.2014887541755510.1128/JVI.03170-1324760886 82.WangW.T.TsaiT.Y.ChaoC.H.LaiB.Y.Wu LeeY.H.Y-Box Binding" exact="Protein" post="1 Stabilizes Hepatitis C Virus NS5A via Phosphorylation-Mediated Interaction"/>
 <result pre="infectious virus productionJ. Virol.2014887541755510.1128/JVI.03170-1324760886 82.WangW.T.TsaiT.Y.ChaoC.H.LaiB.Y.Wu LeeY.H.Y-Box Binding Protein 1 Stabilizes" exact="Hepatitis" post="C Virus NS5A via Phosphorylation-Mediated Interaction with NS5A To"/>
 <result pre="C Virus NS5A via Phosphorylation-Mediated Interaction with NS5A To Regulate" exact="Viral" post="PropagationJ. Virol.201589115841160210.1128/JVI.01513-1526355086 83.StoecklinG.KedershaN.Relationship of GW/P-bodies with stress granulesAdv. Exp."/>
 <result pre="Virol.201286110431105610.1128/JVI.07101-1122855484 87.PeneV.LiQ.SodroskiC.HsuC.S.LiangT.J.Dynamic Interaction of Stress Granules, DDX3X, and IKK-alpha Mediates" exact="Multiple" post="Functions in Hepatitis C Virus InfectionJ. Virol.2015895462547710.1128/JVI.03197-1425740981 88.Valentin-VegaY.A.WangY.D.ParkerM.PatmoreD.M.KanagarajA.MooreJ.RuschM.FinkelsteinD.EllisonD.W.GilbertsonR.J.et al.Cancer-associated"/>
 <result pre="of Stress Granules, DDX3X, and IKK-alpha Mediates Multiple Functions in" exact="Hepatitis" post="C Virus InfectionJ. Virol.2015895462547710.1128/JVI.03197-1425740981 88.Valentin-VegaY.A.WangY.D.ParkerM.PatmoreD.M.KanagarajA.MooreJ.RuschM.FinkelsteinD.EllisonD.W.GilbertsonR.J.et al.Cancer-associated DDX3X mutations drive"/>
 <result pre="(IRES)-Dependent Translation of Enterovirus 71 by DDX3X RNA Helicase and" exact="Viral" post="2A and 3C ProteasesFront Microbiol.20189132410.3389/fmicb.2018.0132429971060 95.LinsalataA.E.HeF.MalikA.M.GlineburgM.R.GreenK.M.NatlaS.FloresB.N.KransA.ArchboldH.C.FedakS.J.et al.DDX3X and specific"/>
 <result pre="XRN1 are recruited to WNV replication sites and positively regulate" exact="viral" post="replicationVirology20134361710.1016/j.virol.2012.09.04123102969 97.KoC.LeeS.WindischM.P.RyuW.S.DDX3 DEAD-box RNA helicase is a host factor"/>
 <result pre="97.KoC.LeeS.WindischM.P.RyuW.S.DDX3 DEAD-box RNA helicase is a host factor that restricts" exact="hepatitis" post="B virus replication at the transcriptional levelJ. Virol.201488136891369810.1128/JVI.02035-1425231298 98.WangH.RyuW.S.Hepatitis"/>
 <result pre="between TBK1/IKKepsilon and DDX3J. Gen. Virol.2010912080209020375222 100.LoretS.GuayG.LippeR.Comprehensive characterization of extracellular" exact="herpes" post="simplex virus type 1 virionsJ. Virol.2008828605861810.1128/JVI.00904-0818596102 101.StegenC.YakovaY.HenaffD.NadjarJ.DuronJ.LippeR.Analysis of virion-incorporated"/>
 <result pre="DDX3J. Gen. Virol.2010912080209020375222 100.LoretS.GuayG.LippeR.Comprehensive characterization of extracellular herpes simplex virus" exact="type 1" post="virionsJ. Virol.2008828605861810.1128/JVI.00904-0818596102 101.StegenC.YakovaY.HenaffD.NadjarJ.DuronJ.LippeR.Analysis of virion-incorporated host proteins required for"/>
 <result pre="1 virionsJ. Virol.2008828605861810.1128/JVI.00904-0818596102 101.StegenC.YakovaY.HenaffD.NadjarJ.DuronJ.LippeR.Analysis of virion-incorporated host proteins required for" exact="herpes" post="simplex virus type 1 infection through a RNA interference"/>
 <result pre="101.StegenC.YakovaY.HenaffD.NadjarJ.DuronJ.LippeR.Analysis of virion-incorporated host proteins required for herpes simplex virus" exact="type 1" post="infection through a RNA interference screenPLoS ONE20138e5327610.1371/journal.pone.005327623301054 102.KhadivjamB.StegenC.Hogue-RacineM.A.El BilaliN.DohnerK.SodeikB.LippeR.The"/>
 <result pre="virion-incorporated host proteins required for herpes simplex virus type 1" exact="infection" post="through a RNA interference screenPLoS ONE20138e5327610.1371/journal.pone.005327623301054 102.KhadivjamB.StegenC.Hogue-RacineM.A.El BilaliN.DohnerK.SodeikB.LippeR.The ATP-Dependent"/>
 <result pre="ExpressionJ. Virol.20179110.1128/JVI.02411-1628148788 103.CavignacY.LieberD.Laib SampaioK.MadlungJ.LamkemeyerT.JahnG.NordheimA.SinzgerC.The Cellular Proteins Grb2 and DDX3 Are" exact="Increased" post="upon Human Cytomegalovirus Infection and Act in a Proviral"/>
 <result pre="Cellular Proteins Grb2 and DDX3 Are Increased upon Human Cytomegalovirus" exact="Infection" post="and Act in a Proviral FashionPLoS ONE201510e013161410.1371/journal.pone.013161426121620 104.DeFilippisV.R.AlvaradoD.SaliT.RothenburgS.FruhK.Human cytomegalovirus"/>
 <result pre="the RNA Helicase DDX19 to Promote the Nuclear Export of" exact="Viral" post="mRNAsSci. Rep.201663376310.1038/srep3376327653209 109.TsaiT.Y.WangW.T.LiH.K.ChenW.J.TsaiY.H.ChaoC.H.Wu LeeY.H.RNA helicase DDX3 maintains lipid homeostasis"/>
 <result pre="and ConsequencesOxid. Med. Cell Longev.20162016891039610.1155/2016/891039627829986 113.IvanovA.V.Valuev-EllistonV.T.TyurinaD.A.IvanovaO.N.KochetkovS.N.BartoschB.IsaguliantsM.G.Oxidative stress, a trigger of" exact="hepatitis" post="C and B virus-induced liver carcinogenesisOncotarget201783895393210.18632/oncotarget.1390427965466 114.KhomichO.A.KochetkovS.N.BartoschB.IvanovA.V.Redox Biology of"/>
 <result pre="hepatitis C and B virus-induced liver carcinogenesisOncotarget201783895393210.18632/oncotarget.1390427965466 114.KhomichO.A.KochetkovS.N.BartoschB.IvanovA.V.Redox Biology of" exact="Respiratory" post="Viral InfectionsViruses20181039210.3390/v1008039230049972 115.AksenovaM.SybrandtJ.CuiB.SikirzhytskiV.JiH.OdhiamboD.LuciusM.D.TurnerJ.R.BroudeE.PenaE.et al.Inhibition of the Dead Box RNA"/>
 <result pre="C and B virus-induced liver carcinogenesisOncotarget201783895393210.18632/oncotarget.1390427965466 114.KhomichO.A.KochetkovS.N.BartoschB.IvanovA.V.Redox Biology of Respiratory" exact="Viral" post="InfectionsViruses20181039210.3390/v1008039230049972 115.AksenovaM.SybrandtJ.CuiB.SikirzhytskiV.JiH.OdhiamboD.LuciusM.D.TurnerJ.R.BroudeE.PenaE.et al.Inhibition of the Dead Box RNA Helicase"/>
 <result pre="Pharmacol.201910.1007/s11481-019-09885-831802418 116.BolG.M.VesunaF.XieM.ZengJ.AzizK.GandhiN.LevineA.IrvingA.KorzD.TantravediS.et al.Targeting DDX3 with a small molecule inhibitor for" exact="lung cancer" post="therapyEMBO Mol. Med.2015764866910.15252/emmm.20140436825820276 117.MagaG.FalchiF.GarbelliA.BelfioreA.WitvrouwM.ManettiF.BottaM.Pharmacophore modeling and molecular docking led"/>
 <result pre="116.BolG.M.VesunaF.XieM.ZengJ.AzizK.GandhiN.LevineA.IrvingA.KorzD.TantravediS.et al.Targeting DDX3 with a small molecule inhibitor for lung" exact="cancer" post="therapyEMBO Mol. Med.2015764866910.15252/emmm.20140436825820276 117.MagaG.FalchiF.GarbelliA.BelfioreA.WitvrouwM.ManettiF.BottaM.Pharmacophore modeling and molecular docking led"/>
 <result pre="molecular docking led to the discovery of inhibitors of human" exact="immunodeficiency" post="virus-1 replication targeting the human cellular aspartic acid-glutamic acid-alanine-aspartic"/>
 <result pre="119.YedavalliV.S.ZhangN.CaiH.ZhangP.StarostM.F.HosmaneR.S.JeangK.T.Ring expanded nucleoside analogues inhibit RNA helicase and intracellular human" exact="immunodeficiency" post="virus type 1 replicationJ. Med. Chem.2008515043505110.1021/jm800332m18680273 120.Heerma van VossM.R.van"/>
 <result pre="nucleoside analogues inhibit RNA helicase and intracellular human immunodeficiency virus" exact="type 1" post="replicationJ. Med. Chem.2008515043505110.1021/jm800332m18680273 120.Heerma van VossM.R.van DiestP.J.RamanV.Targeting RNA helicases"/>
 <result pre="against flaviviridae NTPases/helicases, including those of the West Nile virus," exact="hepatitis" post="C virus, and Japanese encephalitis virusJ. Med. Chem.2003464149416410.1021/jm030842j12954067 122.HosmaneR.S.Ring-expanded"/>
 <result pre="those of the West Nile virus, hepatitis C virus, and" exact="Japanese encephalitis" post="virusJ. Med. Chem.2003464149416410.1021/jm030842j12954067 122.HosmaneR.S.Ring-expanded (&quot;Fat&quot;) nucleosides as broad-spectrum anticancer"/>
 <result pre="of the West Nile virus, hepatitis C virus, and Japanese" exact="encephalitis" post="virusJ. Med. Chem.2003464149416410.1021/jm030842j12954067 122.HosmaneR.S.Ring-expanded (&quot;Fat&quot;) nucleosides as broad-spectrum anticancer"/>
 <result pre="the magic target: Exploiting the diverse roles of DDX3X in" exact="viral" post="infections and tumorigenesisFuture Med. Chem.2019111357138110.4155/fmc-2018-045130816053 124.Heerma van VossM.R.SchrijverW.A.Ter HoeveN.D.HoefnagelL.D.MansonQ.F.van"/>
 <result pre="magic target: Exploiting the diverse roles of DDX3X in viral" exact="infections" post="and tumorigenesisFuture Med. Chem.2019111357138110.4155/fmc-2018-045130816053 124.Heerma van VossM.R.SchrijverW.A.Ter HoeveN.D.HoefnagelL.D.MansonQ.F.van der"/>
 <result pre="der WallE.RamanV.van DiestP.J.The prognostic effect of DDX3 upregulation in distant" exact="breast cancer" post="metastasesClin. Exp. Metastasis201734859210.1007/s10585-016-9832-827999982 125.HeY.ZhangD.YangY.WangX.ZhaoX.ZhangP.ZhuH.XuN.LiangS.A double-edged function of DDX3, as"/>
 <result pre="WallE.RamanV.van DiestP.J.The prognostic effect of DDX3 upregulation in distant breast" exact="cancer" post="metastasesClin. Exp. Metastasis201734859210.1007/s10585-016-9832-827999982 125.HeY.ZhangD.YangY.WangX.ZhaoX.ZhangP.ZhuH.XuN.LiangS.A double-edged function of DDX3, as"/>
 <result pre="Metastasis201734859210.1007/s10585-016-9832-827999982 125.HeY.ZhangD.YangY.WangX.ZhaoX.ZhangP.ZhuH.XuN.LiangS.A double-edged function of DDX3, as an oncogene or" exact="tumor" post="suppressor, in cancer progression (Review)Oncology Rep.20183988389210.3892/or.2018.620329328432 126.ChangP.C.ChiC.W.ChauG.Y.LiF.Y.TsaiY.H.WuJ.C.Wu LeeY.H.DDX3, a"/>
 <result pre="function of DDX3, as an oncogene or tumor suppressor, in" exact="cancer" post="progression (Review)Oncology Rep.20183988389210.3892/or.2018.620329328432 126.ChangP.C.ChiC.W.ChauG.Y.LiF.Y.TsaiY.H.WuJ.C.Wu LeeY.H.DDX3, a DEAD box RNA"/>
 <result pre="126.ChangP.C.ChiC.W.ChauG.Y.LiF.Y.TsaiY.H.WuJ.C.Wu LeeY.H.DDX3, a DEAD box RNA helicase, is deregulated in" exact="hepatitis" post="virus-associated hepatocellular carcinoma and is involved in cell growth"/>
 <result pre="a DEAD box RNA helicase, is deregulated in hepatitis virus-associated" exact="hepatocellular carcinoma" post="and is involved in cell growth controlOncogene2006251991200310.1038/sj.onc.120923916301996 127.BolG.M.RamanV.van der"/>
 <result pre="DEAD box RNA helicase, is deregulated in hepatitis virus-associated hepatocellular" exact="carcinoma" post="and is involved in cell growth controlOncogene2006251991200310.1038/sj.onc.120923916301996 127.BolG.M.RamanV.van der"/>
 <result pre="der WallE.van DiestP.J.Expression of the RNA helicase DDX3 and the" exact="hypoxia" post="response in breast cancerPLoS ONE20138e6354810.1371/journal.pone.006354823696831 128.HeT.Y.WuD.W.LinP.L.WangL.HuangC.C.ChouM.C.LeeH.DDX3 promotes tumor invasion"/>
 <result pre="of the RNA helicase DDX3 and the hypoxia response in" exact="breast" post="cancerPLoS ONE20138e6354810.1371/journal.pone.006354823696831 128.HeT.Y.WuD.W.LinP.L.WangL.HuangC.C.ChouM.C.LeeH.DDX3 promotes tumor invasion in colorectal cancer"/>
 <result pre="and the hypoxia response in breast cancerPLoS ONE20138e6354810.1371/journal.pone.006354823696831 128.HeT.Y.WuD.W.LinP.L.WangL.HuangC.C.ChouM.C.LeeH.DDX3 promotes" exact="tumor" post="invasion in colorectal cancer via the CK1epsilon/Dvl2 axisSci. Rep.201662148310.1038/srep2148326892600"/>
 <result pre="response in breast cancerPLoS ONE20138e6354810.1371/journal.pone.006354823696831 128.HeT.Y.WuD.W.LinP.L.WangL.HuangC.C.ChouM.C.LeeH.DDX3 promotes tumor invasion in" exact="colorectal cancer" post="via the CK1epsilon/Dvl2 axisSci. Rep.201662148310.1038/srep2148326892600 129.Heerma van VossM.R.VesunaF.TrumpiK.BrilliantJ.BerlinickeC.de LengW.KranenburgO.OfferhausG.J.BurgerH.van"/>
 <result pre="in breast cancerPLoS ONE20138e6354810.1371/journal.pone.006354823696831 128.HeT.Y.WuD.W.LinP.L.WangL.HuangC.C.ChouM.C.LeeH.DDX3 promotes tumor invasion in colorectal" exact="cancer" post="via the CK1epsilon/Dvl2 axisSci. Rep.201662148310.1038/srep2148326892600 129.Heerma van VossM.R.VesunaF.TrumpiK.BrilliantJ.BerlinickeC.de LengW.KranenburgO.OfferhausG.J.BurgerH.van"/>
 <result pre="in Wnt-beta-catenin signalingScience20133391436144110.1126/science.123149923413191 131.ChenH.H.YuH.I.ChoW.C.TarnW.Y.DDX3 modulates cell adhesion and motility and" exact="cancer" post="cell metastasis via Rac1-mediated signaling pathwayOncogene2015342790280010.1038/onc.2014.19025043297 132.StranskyN.EgloffA.M.TwardA.D.KosticA.D.CibulskisK.SivachenkoA.KryukovG.V.LawrenceM.S.SougnezC.McKennaA.et al.The mutational"/>
 <result pre="signalingScience20133391436144110.1126/science.123149923413191 131.ChenH.H.YuH.I.ChoW.C.TarnW.Y.DDX3 modulates cell adhesion and motility and cancer cell" exact="metastasis" post="via Rac1-mediated signaling pathwayOncogene2015342790280010.1038/onc.2014.19025043297 132.StranskyN.EgloffA.M.TwardA.D.KosticA.D.CibulskisK.SivachenkoA.KryukovG.V.LawrenceM.S.SougnezC.McKennaA.et al.The mutational landscape of"/>
 <result pre="via Rac1-mediated signaling pathwayOncogene2015342790280010.1038/onc.2014.19025043297 132.StranskyN.EgloffA.M.TwardA.D.KosticA.D.CibulskisK.SivachenkoA.KryukovG.V.LawrenceM.S.SougnezC.McKennaA.et al.The mutational landscape of head" exact="and neck" post="squamous cell carcinomaScience20113331157116010.1126/science.120813021798893 133.ChaoC.H.ChenC.M.ChengP.L.ShihJ.W.TsouA.P.LeeY.H.DDX3, a DEAD box RNA helicase"/>
 <result pre="signaling pathwayOncogene2015342790280010.1038/onc.2014.19025043297 132.StranskyN.EgloffA.M.TwardA.D.KosticA.D.CibulskisK.SivachenkoA.KryukovG.V.LawrenceM.S.SougnezC.McKennaA.et al.The mutational landscape of head and neck" exact="squamous cell" post="carcinomaScience20113331157116010.1126/science.120813021798893 133.ChaoC.H.ChenC.M.ChengP.L.ShihJ.W.TsouA.P.LeeY.H.DDX3, a DEAD box RNA helicase with tumor"/>
 <result pre="squamous cell carcinomaScience20113331157116010.1126/science.120813021798893 133.ChaoC.H.ChenC.M.ChengP.L.ShihJ.W.TsouA.P.LeeY.H.DDX3, a DEAD box RNA helicase with" exact="tumor" post="growth-suppressive property and transcriptional regulation activity of the p21waf1/cip1"/>
 <result pre="transcriptional regulation activity of the p21waf1/cip1 promoter, is a candidate" exact="tumor" post="suppressorCancer Res.2006666579658810.1158/0008-5472.CAN-05-241516818630 134.Heerma van VossM.R.VesunaF.BolG.M.MeeldijkJ.RamanA.OfferhausG.J.BuergerH.PatelA.H.van der WallE.van DiestP.J.et al.Nuclear"/>
 <result pre="DiestP.J.et al.Nuclear DDX3 expression predicts poor outcome in colorectal and" exact="breast" post="cancerOnco. Targets Ther.2017103501351310.2147/OTT.S14063928761359 135.Heerma van VossM.R.KammersK.VesunaF.BrilliantJ.BergmanY.TantravediS.WuX.ColeR.N.HollandA.van DiestP.J.et al.Global Effects"/>
 <result pre="of DDX3 Inhibition on Cell Cycle Regulation Identified by a" exact="Combined" post="Phosphoproteomics and Single Cell Tracking ApproachTransl. Oncol.20181175576310.1016/j.tranon.2018.04.00129684792 136.WilkyB.A.KimC.McCartyG.MontgomeryE.A.KammersK.DeVineL.R.ColeR.N.RamanV.LoebD.M.RNA helicase"/>
 <result pre="mitochondrial translation by inhibiting DDX3: A novel radiosensitization strategy for" exact="cancer" post="treatmentOncogene201837637410.1038/onc.2017.30828869602 138.XieM.VesunaF.TantravediS.BolG.M.Heerma van VossM.R.NugentK.MalekR.GabrielsonK.van DiestP.J.TranP.T.et al.RK-33 Radiosensitizes Prostate Cancer"/>
 <result pre="strategy for cancer treatmentOncogene201837637410.1038/onc.2017.30828869602 138.XieM.VesunaF.TantravediS.BolG.M.Heerma van VossM.R.NugentK.MalekR.GabrielsonK.van DiestP.J.TranP.T.et al.RK-33 Radiosensitizes" exact="Prostate Cancer" post="Cells by Blocking the RNA Helicase DDX3Cancer Res.2016766340635010.1158/0008-5472.CAN-16-044027634756 Figure"/>
 <result pre="for cancer treatmentOncogene201837637410.1038/onc.2017.30828869602 138.XieM.VesunaF.TantravediS.BolG.M.Heerma van VossM.R.NugentK.MalekR.GabrielsonK.van DiestP.J.TranP.T.et al.RK-33 Radiosensitizes Prostate" exact="Cancer" post="Cells by Blocking the RNA Helicase DDX3Cancer Res.2016766340635010.1158/0008-5472.CAN-16-044027634756 Figure"/>
 <result pre="of RecA-like domains supporting ATPase and helicase activities. Figure 2" exact="Local" post="strand separation by DDX3 helicase trimer. Figure 3 Hypothetical"/>
 <result pre="1Table 1 Selected diarylurea derivatives as DDX3 inhibitors in vitro." exact="General" post="Structure A. IC50 1 μM; B. IC50 6 μM"/>
</results>
